Synplogen
Kobe, JapanWebsite
A company specializing in synthetic biology, providing advanced DNA synthesis, viral vector design, and sequence optimization services for gene therapy development.
Loading company information...
A company specializing in synthetic biology, providing advanced DNA synthesis, viral vector design, and sequence optimization services for gene therapy development.
Company context
Synplogen prompts can include culture, product, and business context from this profile.
Role targeting
Pair this profile with an open role to generate focused behavioral and technical questions.
Answer coaching
Practice responses, get feedback, and refine stories before applying or interviewing.
Synplogen Co., Ltd. is a pioneering synthetic biology startup based in Kobe, Japan, that functions as a specialized 'Gene Therapy Biofoundry.' Spun out of Kobe University in 2017, the company focuses on accelerating the development and commercialization of innovative gene therapy products. By providing an integrated, one-stop development value chain, Synplogen supports clients from initial DNA design and sequence optimization through to the manufacturing of viral vectors and mRNA therapeutics.
Synplogen aims to contribute to the early entry into clinical trials and commercialization of innovative gene therapy products by providing high-quality, cost-effective, and integrated development and manufacturing value chains.
Founded
2017
Headquarters
Kobe, Japan
Employees
11-50
Industry
Biotech
Opportunity to work at the cutting edge of synthetic biology and gene therapy research.
Collaborative environment with high-profile international partners like Ginkgo Bioworks and Merck.
As a specialized startup, the work environment may be fast-paced and high-pressure.
Funding
Series D
CEO
Kazuhiko Yamamoto
Limited public information regarding internal employee benefits and corporate culture.